| 000 | 01532 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517121310.0 | ||
| 264 | 0 | _c20170926 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-016-2827-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Zi-Ying | |
| 245 | 0 | 0 |
_aIntrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. _h[electronic resource] |
| 260 |
_bBMC cancer _c10 2016 |
||
| 300 |
_a792 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBile Duct Neoplasms _xblood |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aC-Reactive Protein |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPreoperative Period |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aROC Curve |
| 700 | 1 | _aLiang, Zhen-Xing | |
| 700 | 1 | _aZhuang, Pei-Lin | |
| 700 | 1 | _aChen, Jie-Wei | |
| 700 | 1 | _aCao, Yun | |
| 700 | 1 | _aYan, Li-Xu | |
| 700 | 1 | _aYun, Jing-Ping | |
| 700 | 1 | _aXie, Dan | |
| 700 | 1 | _aCai, Mu-Yan | |
| 773 | 0 |
_tBMC cancer _gvol. 16 _gno. 1 _gp. 792 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-016-2827-7 _zAvailable from publisher's website |
| 999 |
_c26508817 _d26508817 |
||